Pfizer JV plans R&D center in China; Valeant to sell $1.75B in debt to pay for Medicis;

 @FiercePharma: Working Mother's Top 100 employers list includes 10 drugmakers. Discrimination lawsuits (for some) notwithstanding. More | Follow @FiercePharma

> Pfizer ($PFE) and its Chinese joint venture partner Zhejiang Hisun Pharmaceuticals is planning a dedicated research center to develop generic drugs for the Chinese market. Report

> Valeant Pharmaceuticals ($VRX) announced a $1.75 billion debt offering to help finance its planned acquisition of Medicis Pharmaceutical. Report

> Vertex Pharmaceuticals ($VRTX) tapped IBM enterprise marketing executive Yuchun Lee to join its board of directors. Report

> Xanodyne Pharmaceuticals won FDA approval for its Lysteda tablet to treat heavy menstrual bleeding, the first non-hormonal drug for the condition. Report

> Tranzyme Pharma said its stock offering delivered $11.5 million, including the underwriters' over-allotment. Report

Medical Device News

 @FierceMedDev: Japan's Olympus (makes med equipment/cameras) may be very close to getting a huge investment from Sony. WSJ reports. More | Follow @FierceMedDev

 @MarkHFierce: The U.S.'s othopedic soft tissue device market should grow to $2 billion by 2016, Millennium Research Group believes. More | Follow @MarkHFierce

 @DamianFierce: Torax Medical snagged $30M in VC funding to market its anti-acid reflux device. Story | Follow @DamianFierce

> U-Systems gains FDA nod for dense breast tissue cancer ultrasound. News

> Boston Sci, Medtronic reignite patent spat after court ruling. Article

Biotech News

 @FierceBiotech: Craigslist.com fuels biotech's hunt for flu therapies. Story | Follow @FierceBiotech

 @JohnCFierce: The Fierce 15: An appetite for risk is healthy in drug development. Report | Follow @JohnCFierce

 @RyanMFierce: 10 pharma giants form nonprofit to gang up on common R&D foes. More | Follow @RyanMFierce

> Baxter and Onconova ink $500M-plus licensing pact for PhIII cancer drug. News

> After FDA blessings for diet drugs, spotlight shines on biotechs' pioneering obesity meds. More

> Wellington Partners rounds up $91M for new European life sciences fund. Article

Drug Delivery News

> Fast migraine treatment battles sickness, too. Story

> BDSI's addiction oral patch approaches the market. Article

> Origami DNA may take twist out of doxorubicin delivery. News

> Ultrasound gets drugs right under the skin. More

Biomarkers News

> Genetic biomarkers and the frets of the 'worried well'. More

> Gene mutations point to personalized therapy in lung cancer. Story

> Breath biomarkers could breathe life into lung cancer tests. Article

> BRCA mutations may pinpoint response to Abbott's veliparib. News

And Finally ... A British study identified biomarkers that could improve depression treatment by identifying patients most likely to be resistant to standard therapy. Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.